)
Alumis (ALMS) investor relations material
Alumis Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of three Class II director nominees to serve until the 2029 annual meeting: James B. Tananbaum, M.D., Lynn Tetrault, J.D., and Zhengbin (Bing) Yao, Ph.D. are recommended for election.
Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends the election of the three named director nominees for multi-year terms ending in 2029.
Audit committee and external auditor matters
Proposal to ratify PricewaterhouseCoopers LLP as the external auditor for the 2026 fiscal year.
- Annual meeting to elect directors and ratify auditor, with strong governance and transparency.ALMS
Proxy filing18 May 2026 - Envudeucitinib delivers leading efficacy in psoriasis, with broad TYK2 franchise potential.ALMS
Corporate presentation14 May 2026 - Envudeucitinib's Phase 3 success drives NDA plans as $569.5M cash supports operations into 2027.ALMS
Q1 202614 May 2026 - Envudeucitinib achieved rapid, sustained skin clearance and symptom relief with strong safety in Phase 3 trials.ALMS
Study update30 Mar 2026 - Envudeucitinib achieved top Phase 3 results in psoriasis, driving a high-value, multi-indication pipeline.ALMS
Corporate presentation19 Mar 2026 - Envudeucitinib's Phase 3 success and robust financing position operations through late 2027.ALMS
Q4 202519 Mar 2026 - Envudeucitinib delivers leading efficacy in psoriasis, with broad TYK2 franchise expansion ahead.ALMS
Leerink Global Healthcare Conference 20269 Mar 2026 - Strong Phase 3 psoriasis data and NDA planned; SLE pivotal trial readout expected in Q3.ALMS
Oppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026 - Strong phase III psoriasis results and robust pipeline expansion, with NDA filing expected this year.ALMS
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
Next Alumis earnings date
Next Alumis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage